Furthermore, SESN2 may inhibit the production of ROS and produce antioxidant effects, making it a potential target for the treatment of AD and neurodegenerative diseases, as AD neuronal death is likely caused by oxidative damage (Wang et al., 2019). This evidence concerns the gene SESN2 and neurodegenerative disease.